<!DOCTYPE html>
<html>
<head>
	<title></title>
	<style type="text/css">
		ul{
			list-style-type: none;
			margin: 0px;
			padding: 0px;
			overflow: hidden;
			background-color: #1587a1;
			width: 90%;
			height:100px;
		}
		li{
			float: left;
		}
		li a{
			display: block;
			text-decoration: none; 
			text-align: center;
			padding:50px 200px;
			color: black;
		}
		a:hover{
			background-color: #03fca1;
		}
	</style>
</head>
<body>

	<div style="width: 100%;height: 1650px;background-color: #2b5059;">
		<div style="width: 100%;height: 100px;background-color: #c7cfd1;">
			<div style="float: left;width: 10%;height: 100px;">
				<h2 style="margin-left: 25px;padding-top: 15px;">Genmab</h2>
			</div>
			<div>
			<ul>
				<li><a href="corporatewebsite.html">Home</a></li>
				<li><a href="products.html">Products</a></li>
				<li><a href="trials.html">Trials</a></li>
				
			</ul>
			</div>
		</div>
		<div style="width: 100%;height: 500px;background-color: #2b5059;">
			<div style="float: left;width: 50%;height: 500px;">
				<h2 style="margin-left: 300px;padding-top: 150px;">Trials</h2><br>
				<h4 style="margin-left: 20px;">Learn more about ongoing clinical trials involving Genmab products. Use the options below to choose which trials you wish to view.</h4>
			</div>
			<div style="width: 50%;height: 500px;float: left;">
				<img src="1.jpg" alt="food" width="100%" height="100%">
			</div>
		</div>
		<div style="width: 100%;height: 100px;background-color: #1587a1;">
			<h6 style="text-align: center;padding-top: 45px;">The safety and efficacy of investigational agents and/or investigational uses of approved products have not been established.</h6>
		</div>
		<div style="width: 100%;height: 500px;background-color:  #c7cfd1;padding-top: 150px;">
			<div style="width: 40%;height: 400px;background-color:white ;float: left;margin-left: 120px;">

				<h2 style="text-align: center;">DuoBody®-CD3xB7H4 (GEN1047)</h2>
				<h4 style="text-align: center;">Cancer Type:Solid Tumors</h4><br>
				<h4 style="text-align: center;">The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.</h4>
				
                               
			</div>
			<div style="width: 40%;height:400px;background-color: white;float: right;margin-right:120px; ">

				<h2 style="text-align: center;">DuoBody®-CD40x4-1BB (GEN1042)</h2>
				<h4 style="text-align: center;">Cancer Type:Hematologic Malignancies</h4><br>
				<h4 style="text-align: center;">The drug that will be investigated in the study is an antibody, GEN1047. Since this is the first study of GEN1047 in humans, the main purpose is to evaluate safety. Besides safety, the study will determine the recommended GEN1047 dose to be tested in a larger group of participants and assess preliminary clinical activity of GEN1047. GEN1047 will be studied in a broad group of cancer patients, having different kinds of solid tumors. All participants will get GEN1047. The study consists of two parts: Part 1 tests increasing doses of GEN1047 ("escalation"), followed by Part 2 ("expansion") which tests the recommended GEN1047 dose from Part 1.</h4>
				
			</div>
		</div>
		<div style="width: 100%;height: 450px;">
			<div style="width: 50%;height: 450px;float: left;">
				<h2>Address</h2>
				<h4>777 Scudders Mill Road</h4>
				<h4>Plainsboro, NJ 08536</h4>
				<h4>USA</h4>
			</div>
			<div style="width: 50%;height: 450px;float: left;">
				<iframe src="https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d25895663.485556163!2d-95.665!3d37.599999999999994!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x54eab584e432360b%3A0x1c3bb99243deb742!2sUnited%20States!5e0!3m2!1sen!2sin!4v1675233703387!5m2!1sen!2sin" width="100%" height="275" style="border:0;" allowfullscreen="" loading="lazy" referrerpolicy="no-referrer-when-downgrade"></iframe>
			</div>
		</div>
	</div>

</body>
</html>